Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P9
Near historical low
vs 2Y Ago
-0.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -6.19% |
| Q3 2025 | 6.36% |
| Q2 2025 | -3.32% |
| Q1 2025 | 3.41% |
| Q4 2024 | 2.89% |
| Q3 2024 | 24.73% |
| Q2 2024 | 7.53% |
| Q1 2024 | 13.26% |
| Q4 2023 | 13.92% |
| Q3 2023 | -31.51% |
| Q2 2023 | 3.92% |
| Q1 2023 | 0.00% |